These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 17400730

  • 1. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia.
    Ernst P, Gonzalez AV, Brassard P, Suissa S.
    Am J Respir Crit Care Med; 2007 Jul 15; 176(2):162-6. PubMed ID: 17400730
    [Abstract] [Full Text] [Related]

  • 2. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD.
    Joo MJ, Au DH, Fitzgibbon ML, Lee TA.
    Respir Med; 2010 Feb 15; 104(2):246-52. PubMed ID: 19879745
    [Abstract] [Full Text] [Related]

  • 3. Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias.
    Kiri VA, Pride NB, Soriano JB, Vestbo J.
    Am J Respir Crit Care Med; 2005 Aug 15; 172(4):460-4. PubMed ID: 15901610
    [Abstract] [Full Text] [Related]

  • 4. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr 15; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 5. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis.
    Fan VS, Bryson CL, Curtis JR, Fihn SD, Bridevaux PO, McDonell MB, Au DH.
    Am J Respir Crit Care Med; 2003 Dec 15; 168(12):1488-94. PubMed ID: 14525798
    [Abstract] [Full Text] [Related]

  • 6. Impact of regular inhaled corticosteroid use on chronic obstructive pulmonary disease outcomes.
    Vollmer WM, Peters D, Crane B, Kelleher C, Buist AS.
    COPD; 2007 Jun 15; 4(2):135-42. PubMed ID: 17530507
    [Abstract] [Full Text] [Related]

  • 7. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD.
    Thornton Snider J, Luna Y, Wong KS, Zhang J, Chen SS, Gless PJ, Goldman DP.
    Curr Med Res Opin; 2012 Dec 15; 28(12):1959-67. PubMed ID: 23098081
    [Abstract] [Full Text] [Related]

  • 8. Discontinuation of Inhaled Corticosteroids in COPD and the Risk Reduction of Pneumonia.
    Suissa S, Coulombe J, Ernst P.
    Chest; 2015 Nov 15; 148(5):1177-1183. PubMed ID: 26110239
    [Abstract] [Full Text] [Related]

  • 9. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.
    Singh S, Amin AV, Loke YK.
    Arch Intern Med; 2009 Feb 09; 169(3):219-29. PubMed ID: 19204211
    [Abstract] [Full Text] [Related]

  • 10. Inhaled corticosteroids and pneumonia in COPD: an association looking for evidence.
    Turner MO.
    Am J Respir Crit Care Med; 2008 Mar 01; 177(5):555-6; author reply 556. PubMed ID: 18296470
    [No Abstract] [Full Text] [Related]

  • 11. The Risk of Sepsis with Inhaled and Oral Corticosteroids in Patients with COPD.
    Ernst P, Coulombe J, Brassard P, Suissa S.
    COPD; 2017 Apr 01; 14(2):137-142. PubMed ID: 28010132
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies.
    Suissa S.
    Am J Respir Crit Care Med; 2003 Jul 01; 168(1):49-53. PubMed ID: 12663327
    [Abstract] [Full Text] [Related]

  • 13. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug 01; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

  • 14. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
    Lee TA, Wilke C, Joo M, Stroupe KT, Krishnan JA, Schumock GT, Pickard AS.
    Arch Intern Med; 2009 Aug 10; 169(15):1403-10. PubMed ID: 19667304
    [Abstract] [Full Text] [Related]

  • 15. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis.
    Andréjak C, Nielsen R, Thomsen VØ, Duhaut P, Sørensen HT, Thomsen RW.
    Thorax; 2013 Mar 10; 68(3):256-62. PubMed ID: 22781123
    [Abstract] [Full Text] [Related]

  • 16. Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease.
    Lee TA, Weiss KB.
    Am J Respir Crit Care Med; 2004 Apr 01; 169(7):855-9. PubMed ID: 14711795
    [Abstract] [Full Text] [Related]

  • 17. [Inhaled corticosteroids in COPD and the risk of pneumonia].
    Niţu M, Medregoniu D, Olteanu M, Golli A, Olteanu M, Măceşeanu A, Medregoniu R.
    Pneumologia; 2010 Apr 01; 59(2):74-6. PubMed ID: 20695361
    [Abstract] [Full Text] [Related]

  • 18. Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease and Risk of Pneumonia: A Nested Case-Control Population-based Study in Lazio (Italy)-The OUTPUL Study.
    Cascini S, Kirchmayer U, Belleudi V, Bauleo L, Pistelli R, Di Martino M, Formoso G, Davoli M, Agabiti N.
    COPD; 2017 Jun 01; 14(3):311-317. PubMed ID: 28406337
    [Abstract] [Full Text] [Related]

  • 19. Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease.
    Pujades-Rodríguez M, Smith CJ, Hubbard RB.
    QJM; 2007 Aug 01; 100(8):509-17. PubMed ID: 17609226
    [Abstract] [Full Text] [Related]

  • 20. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L.
    Am J Geriatr Pharmacother; 2008 Aug 01; 6(3):138-46. PubMed ID: 18775388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.